Cadence Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-11,840
Closed -$535K 641
2015
Q3
$535K Buy
+11,840
New +$559K 0.04% 436
2014
Q1
Sell
-163,110
Closed -$5.84M 644
2013
Q4
$5.84M Buy
163,110
+87,750
+116% +$2.91M 0.22% 168
2013
Q3
$2.27M Sell
75,360
-158,860
-68% -$5.19M 0.08% 327
2013
Q2
$6.83M Buy
+234,220
New +$6.6M 0.32% 153

Other funds holding PBH

Cadence Capital Management's PBH Position: Q4 2015 in Review

Cadence Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2015, closing a stake of 11,840 shares — an estimated $535K sold.

Cadence Capital Management first reported a position in PBH in Q2 2013 and held it in 4 quarters. The position peaked at $6.83M in Q2 2013. 235 funds tracked by Wall St. Rank hold PBH as of Q4 2015.

  • Cadence Capital Management reported no remaining Prestige Consumer Healthcare position as of Q4 2015 after selling out during the quarter.
  • Cadence Capital Management sold 11,840 Prestige Consumer Healthcare shares in Q4 2015, an estimated $535K.
  • Cadence Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 4 quarters.
  • Cadence Capital Management's Prestige Consumer Healthcare position peaked at $6.83M in Q2 2013.
  • 235 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2015.

Based on Cadence Capital Management's 13F filing for Q4 2015, filed 3 Feb 2016.